메뉴 건너뛰기




Volumn 192, Issue 5 SPEC. ISS., 2005, Pages 1365-1367

Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer

Author keywords

Carboplatin; Endometrial cancer; Paclitaxel; Taxol

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; PACLITAXEL;

EID: 20644447350     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.12.032     Document Type: Article
Times cited : (56)

References (7)
  • 2
    • 0024602787 scopus 로고
    • Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study
    • DOI 10.1016/0090-8258(89)90605-7
    • Thigpen JT, Blessing JA, Homesley H, Creasman WT, Sutton G. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a gynecologic oncology group study. Gynecol Oncol 1989;33:68-70. (Pubitemid 19106626)
    • (1989) Gynecologic Oncology , vol.33 , Issue.1 , pp. 68-70
    • Thigpen, J.T.1    Blessing, J.A.2    Homesley, H.3    Creasman, W.T.4    Sutton, G.5
  • 4
    • 0030220145 scopus 로고    scopus 로고
    • A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: A Gynecologic Oncology Group Study
    • DOI 10.1006/gyno.1996.0227
    • Ball HG, Blessing JA, Lentz SS, Mutch DG. A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a gynecologic oncology group study. Gynecol Oncol 1996;62:278-81. (Pubitemid 26274811)
    • (1996) Gynecologic Oncology , vol.62 , Issue.2 , pp. 278-281
    • Ball, H.G.1    Blessing, J.A.2    Lentz, S.S.3    Mutch, D.G.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.